Core Laboratories (CLB) Accumulated Expenses (2022 - 2026)

Core Laboratories' Accumulated Expenses history runs 5 years deep, the most recent figure standing at $22.3 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 7.29% year-over-year to $22.3 million in Q1 2026; TTM through Mar 2026 was $22.3 million, a 7.29% decrease from a year earlier, with the FY2025 full-year figure at $26.5 million, up 15.82% from the prior year.
• Accumulated Expenses slipped to $22.3 million in Q1 2026 per CLB's latest filing, from $26.5 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $26.5 million in Q4 2025 and bottomed at $18.8 million in Q4 2023.
• The 5-year median for Accumulated Expenses is $22.3 million (2026), against an average of $22.4 million.
• Across the five-year window, Accumulated Expenses slipped 19.8% in 2023 and gained 21.87% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $23.4 million in 2022, then declined by 19.8% to $18.8 million in 2023, then gained by 21.87% to $22.9 million in 2024, then climbed by 15.82% to $26.5 million in 2025, then fell by 15.95% to $22.3 million in 2026.
• Per Business Quant, the three latest CLB Accumulated Expenses figures stand at $22.3 million (Q1 2026), $26.5 million (Q4 2025), and $23.4 million (Q3 2025).